Brad Starkey, MD
Anesthesiology · Oklahoma City, OKNPI 1497739437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Medtronic at 28.2% of the total. 2025 is the largest year on record at $1,759, 2.1 times the $826 reported in 2019. Among anesthesiology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $36.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Saluda Medical Americas, Inc.$902
- Nevro Corp.$699
- Boston Scientific$682
- Abbott$592
- Averitas Pharma Inc.$575
- plus $2K from 29 others
What the payments were for
- Travel & lodging$1472%
- Food & beverage$7,57598%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 30 | $2,174 |
| Saluda Medical Americas, Inc. | 17 | $902 |
| Nevro Corp. | 11 | $699 |
| Boston Scientific | 7 | $682 |
| Abbott | 19 | $592 |
| Averitas Pharma Inc. | 12 | $575 |
| Collegium Pharmaceutical, Inc. | 24 | $379 |
| GRT US Holding, Inc. | 14 | $267 |
| Si-bone, Inc. | 2 | $183 |
| Scilex Pharmaceuticals Inc. | 10 | $164 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $163 |
| Globus Medical | 1 | $96 |
| AbbVie | 6 | $85 |
| Merck | 5 | $79 |
| Daiichi Sankyo Inc. | 4 | $74 |
| Eisai Inc. | 5 | $68 |
| UCB, Inc. | 3 | $66 |
| Biodelivery Sciences International, Inc. | 3 | $56 |
| Tersera Therapeutics LLC | 3 | $55 |
| Indivior Inc. | 3 | $53 |
| Pfizer | 3 | $48 |
| Redhill Biopharma Inc. | 2 | $31 |
| Kaleo, Inc. | 2 | $28 |
| Baudax Bio Inc. | 1 | $23 |
| Vertex | 1 | $22 |
| Bioventus LLC | 1 | $20 |
| Amgen | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Sentynl Therapeutics, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Valinor Pharma, LLC | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$854
- Qutenza$533
- Evoke$459
- WaveWriter Alpha Prime 16$422
- INTELLIS$268
- Senza Spinal Cord Stimulation System$265
- Evoke SCS$261
- INCEPTIV$247
- PROCLAIM$167
- GENERAL PAIN MANAGEMENT$137
- Proclaim IPG$115
- Omnia$101
- SYNCHROMEDII$101
How this compares
$7,722 in reported general payments places this provider in the 95th percentile of 476 anesthesiology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 144 | $127,723 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,529 | $92,462 |
| Xtampza ErOxycodone Myristate | 100 | $45,936 |
| RelistorMethylnaltrexone Bromide | 17 | $40,740 |
| Buprenorphine | 134 | $39,899 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,091 | $38,790 |
| MovantikNaloxegol Oxalate | 90 | $36,024 |
| ZtlidoLidocaine | 51 | $31,230 |
| BelsomraSuvorexant | 70 | $30,604 |
| Tramadol Hcl ErTramadol Hcl | 282 | $15,136 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 119 | $12,252 |
| Buprenorphine Hcl | 274 | $10,341 |
| LinzessLinaclotide | 17 | $9,442 |
| Pregabalin | 452 | $9,107 |
| Naloxone Hcl | 136 | $8,792 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $379 | $173,659244 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $163 | $40,74017 claims |
| Redhill Biopharma Inc.Movantik | $31 | $36,02490 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $164 | $31,23051 claims |
| MerckBelsomra | $79 | $30,60470 claims |
| AbbVieLinzess | $85 | $9,44217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 476 anesthesiology providers in Oklahoma.
Other anesthesiology in Oklahoma City
- Garrett WrightOklahoma City$73K
- Kenichi TanakaOklahoma City$68K
- Robert SchoapsOklahoma City$54K
- Michael ElderOklahoma City$8K
- George SmithOklahoma City$6K
- Chun KwanOklahoma City$6K
- Kofi VandyckOklahoma City$4K
- James SweetOklahoma City$4K
- Jennifer HolemanOklahoma City$4K
- Alberto de ArmendiOklahoma City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.